High Growth Tech Stocks In Hong Kong Including AAC Technologies Holdings And Two More

In This Article:

As global markets react positively to China's new stimulus measures, the Hong Kong market has seen a significant uptick, with technology stocks particularly benefiting from the renewed investor confidence. In this environment of heightened optimism, identifying high-growth tech stocks like AAC Technologies Holdings and others becomes crucial for investors looking to capitalize on the sector's potential.

Top 10 High Growth Tech Companies In Hong Kong

Name

Revenue Growth

Earnings Growth

Growth Rating

Wasion Holdings

22.37%

25.47%

★★★★★☆

MedSci Healthcare Holdings

48.74%

48.78%

★★★★★☆

Inspur Digital Enterprise Technology

25.31%

39.04%

★★★★★☆

Akeso

32.58%

54.53%

★★★★★★

RemeGen

26.30%

52.19%

★★★★★☆

Cowell e Holdings

31.82%

35.43%

★★★★★★

Innovent Biologics

22.24%

59.39%

★★★★★☆

Sichuan Kelun-Biotech Biopharmaceutical

24.70%

8.53%

★★★★★☆

Biocytogen Pharmaceuticals (Beijing)

21.53%

109.17%

★★★★★☆

Beijing Airdoc Technology

37.47%

93.35%

★★★★★☆

Click here to see the full list of 45 stocks from our SEHK High Growth Tech and AI Stocks screener.

Let's dive into some prime choices out of from the screener.

AAC Technologies Holdings

Simply Wall St Growth Rating: ★★★★☆☆

Overview: AAC Technologies Holdings Inc., an investment holding company, offers solutions for smart devices across various regions including Mainland China, Hong Kong, Taiwan, other Asian countries, the United States, and Europe with a market cap of HK$37.51 billion.

Operations: AAC Technologies Holdings Inc. generates revenue primarily from its Optics Products (CN¥4.07 billion), Acoustics Products (CN¥7.64 billion), Sensor and Semiconductor Products (CN¥0.92 billion), and Electromagnetic Drives and Precision Mechanics (CN¥8.28 billion). The company operates across various regions, including Mainland China, Hong Kong, Taiwan, other Asian countries, the United States, and Europe.

AAC Technologies Holdings has demonstrated a robust financial performance with a notable increase in sales from CNY 9.22 billion to CNY 11.25 billion and a surge in net income from CNY 150.3 million to CNY 537.03 million within the first half of 2024 alone, underscoring its potential in high-growth tech sectors. The company's commitment to innovation is evident from its R&D investments, aligning with an expected annual profit growth rate of 21%, significantly outpacing the Hong Kong market average of 12%. This growth trajectory is supported by strategic moves such as the recent relocation of its principal business place to Wanchai, enhancing operational efficiencies and client engagement amidst dynamic market conditions.